4 years after withdrawal of rofecoxib: where do we stand today?

Author： Jaksch W.  

Publisher： Springer Publishing Company

ISSN： 0172-8172

Source： Rheumatology International, Vol.28, Iss.12, 2008-10, pp. : 1187-1195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Challenges of RSV Vaccines. Where do we Stand?

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 99-108

Bentham Science Publishers

Access to resources Recommend Favorite

Imaging Subclinical Atherosclerosis: Where Do We Stand?

By  

Current Cardiology Reviews, Vol. 13, Iss. 1, 2016-11 ,pp. : 47-55

Bentham Science Publishers

Access to resources Recommend Favorite

Omega 3: Where Do We Stand?

By Versari Daniele   Daghini Elena   Salvetti Guido   Salvetti Antonio  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

Gastric Electrical Stimulation in Gastroparesis: Where Do We Stand?

By  

Digestive Diseases, Vol. 24, Iss. 3-4, 2006-07 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

Prebiotics and Probiotics in Ulcerative Colitis: Where Do We Stand?

By  

Digestion, Vol. 84, Iss. 2, 2011-04 ,pp. : 126-127

Karger

Access to resources Recommend Favorite